Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients

about

Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.

P2860

Q40151539-85A92D1B-7898-4DFA-A14C-0A7399D8006B

P2860

Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients

Item

http://www.wikidata.org/entity/Q36742108

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fludarabine and busulfan as a ...... on for acute leukemia patients

@ast

Fludarabine and busulfan as a ...... on for acute leukemia patients

@en

type

Item

label

Fludarabine and busulfan as a ...... on for acute leukemia patients

@ast

Fludarabine and busulfan as a ...... on for acute leukemia patients

@en

prefLabel

Fludarabine and busulfan as a ...... on for acute leukemia patients

@ast

Fludarabine and busulfan as a ...... on for acute leukemia patients

@en

P1476

Fludarabine and busulfan as a ...... on for acute leukemia patients

@en

P2093

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Wang-Gang Zhang

http://www.w3.org/2001/XMLSchema#string

Xingmei Cao

http://www.w3.org/2001/XMLSchema#string

Yang Zhang

http://www.w3.org/2001/XMLSchema#string

Zhijun Dai

http://www.w3.org/2001/XMLSchema#string

Zhiming Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and mu

P304

667-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2016.765

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293009439

http://www.w3.org/2001/XMLSchema#string

P698

27073687

http://www.w3.org/2001/XMLSchema#string

P932

4812520

http://www.w3.org/2001/XMLSchema#string

Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients

about

P2860

P2860

Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932